ArticleCancers2020

A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.

Lorena Incorvaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.